"Genentech is well-positioned to bring these ... This is not the first big pharma deal for Regor: in 2021, the company entered into a strategic research collaboration with Eli Lilly around its ...

Roche’s Genentech unit is to partner with South Korea’s Hanmi Pharmaceutical, to develop and market a phase 1 cancer drug, in a deal potentially worth over $900 million. Under the agreement ...

Genentech is a biotechnology company on the forefront of treating people with hemophilia, a medical condition that significantly reduces the ability of blood to clot, through its Hemlibra brand of ...

The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.26%, which has investors questioning if this is right time ...

Rajwinder Mehdwan appointed as General Manager of Roche Pharma India, joining leadership team for CEETRIS region.

I’d like to think that Genentech and many other companies in our industry are starting to follow that approach. *This program requires pharmaceutical manufacturers in Medicaid to sell drugs at ...

Roche Pharma India appoints Rajwinder as new country general manager to propel growth and innovation: Our Bureau, Bengaluru ...